1. Home
  2. SCLX vs TGHL Comparison

SCLX vs TGHL Comparison

Compare SCLX & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$0.57

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Logo The GrowHub Limited Class A Ordinary Shares

TGHL

The GrowHub Limited Class A Ordinary Shares

HOLD

Current Price

$0.28

Market Cap

11.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
TGHL
Founded
2011
2020
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
11.9M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
SCLX
TGHL
Price
$0.57
$0.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
73.1K
★ 493.6K
Earning Date
12-01-2026
12-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $30,253,000.00
N/A
Revenue This Year
$118.16
N/A
Revenue Next Year
$186.31
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.54
$0.25
52 Week High
$23.03
$2.48

Technical Indicators

Market Signals
Indicator
SCLX
TGHL
Relative Strength Index (RSI) 8.42 35.34
Support Level N/A N/A
Resistance Level $7.77 $0.42
Average True Range (ATR) 0.17 0.10
MACD -0.04 -0.01
Stochastic Oscillator 2.80 3.08

Price Performance

Historical Comparison
SCLX
TGHL

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About TGHL The GrowHub Limited Class A Ordinary Shares

The Growhub Ltd operates as the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, the company has developed a multi-faceted approach to address industry challenges. Its business currently comprises two main divisions, which are the Traceability and Authenticity Solutions and Carbon Project Development.

Share on Social Networks: